# Apitoria Pharma Private Limited - Inspection Records

Source: https://www.keypedia.com/companies/apitoria-pharma-private-limited/3fa64839-667a-4ce5-930b-a1935f0c2b38

> Inspection records and compliance data for Apitoria Pharma Private Limited in Sangareddy District, None. Access full analysis and detailed observations.

---

## Details

- Name: Apitoria Pharma Private Limited
- FEI Number: 3004086884
- City: Sangareddy District
- State: None
- Country Name: India
- Address Line 1: Survey No. 10 & 13, Gaddapotharam Village, Ida-Kazipally, Jinnaram Mandal
- Zip Code: None
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Apitoria Pharma Private Limited - 2024-09-27](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/c88a9780-f209-45af-8216-dbd21e03a3ee) — source: FDA, date: September 27, 2024
- [483 - Apitoria Pharma Private Limited - 2024-09-27](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/d70a197d-94fc-49c8-88c7-eb078a386f9f) — source: FDA, date: September 27, 2024
- [FDA Inspection 1254546 - Apitoria Pharma Private Limited - 2024-09-27](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/d9ff7823-1faa-4886-894f-1ee56c2cee09) — source: FDA, date: September 27, 2024
- [FDA Inspection 1254546 - Apitoria Pharma Private Limited - 2024-09-27](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/2ddc997e-dbf0-406b-acdb-bfae0099ed0f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2024
- [483 - Apitoria Pharma Private Limited - 2019-10-25](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/c0a8f710-466e-418e-9774-c7f4bef69156) — source: FDA, date: October 25, 2019
- [483 - Apitoria Pharma Private Limited - 2019-10-25](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/d9f84278-4c1a-4baf-beae-f2d5ce74b3b1) — source: FDA, date: October 25, 2019
- [FDA Inspection 1116242 - Apitoria Pharma Private Limited - 2019-10-25](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/d0d6f586-0d35-42dd-bd42-3dcb2fd53f4e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2019
- [FDA Inspection 1060097 - Apitoria Pharma Private Limited - 2018-06-11](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/cf8dee11-3916-4788-85bf-354c8a798a67) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2018
- [483 - Apitoria Pharma Private Limited - 2016-07-01](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/6f2a3f13-62ed-4024-b141-70e9668fa578) — source: FDA, date: July 1, 2016
- [FDA Inspection 979741 - Apitoria Pharma Private Limited - 2016-07-01](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/a4049dc5-8b0a-4338-9d08-b3f299fca6a8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 1, 2016
- [FDA Inspection 892453 - Apitoria Pharma Private Limited - 2014-04-19](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/bb20e24d-8cf7-46f0-866b-086baa932680) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 19, 2014
- [FDA Inspection 728788 - Apitoria Pharma Private Limited - 2011-05-26](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/0e45ba4f-57ce-4900-b69a-25934b41a10a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2011

## Related Companies

- [Chinese Peptide Company](https://www.keypedia.com/companies/chinese-peptide-company/ba8c6a32-f679-405b-bb0a-e82713b7cb62)
- [Takeda Manufacturing Singapore Pte. Ltd.](https://www.keypedia.com/companies/takeda-manufacturing-singapore-pte-ltd/4ae048ca-a89e-47c7-b5a2-60d372157742)
- [Dr. Reddy's Laboratories New York, Inc.](https://www.keypedia.com/companies/dr-reddys-laboratories-new-york-inc/0eed3dcf-9a65-422d-95f0-c7fe0ec7debd)
- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)

## Related Officers

- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [PreApproval Manager](https://www.keypedia.com/people/gayle-s-lawson/cd8061de-f089-408c-bbfc-c7c7a5635dd7)
- [Kenneth H. Williams](https://www.keypedia.com/people/kenneth-h-williams/20a225cd-a3d5-478f-ae04-2a8e119df8a6)